Molecular mechanisms of cytokine-induced modulation of T cell antigen receptor responsiveness
细胞因子诱导的 T 细胞抗原受体反应性调节的分子机制
基本信息
- 批准号:RGPIN-2020-04804
- 负责人:
- 金额:$ 2.33万
- 依托单位:
- 依托单位国家:加拿大
- 项目类别:Discovery Grants Program - Individual
- 财政年份:2021
- 资助国家:加拿大
- 起止时间:2021-01-01 至 2022-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The overall objective of this research program is to understand how inflammatory cytokines produced during innate immune responses impact on the adaptive immune responses of cytotoxic T lymphocytes. Cytokine responses are regulated by `suppressors of cytokine signaling' (SOCS) family proteins. While studying the deregulated homeostasis of the T cell compartment in mice lacking SOCS1, we made a fortuitous observation: SOCS1-deficient CD8 T cells proliferate robustly in response to cytokines that regulate T cell homeostasis and this is amplified by inflammatory cytokines; while this was not unexpected, CD8 T cells from control mice also proliferated in response to synergistic stimulation by inflammatory and homeostatic cytokines. The latter was unexpected because normal T cells require two signals - one via the antigen receptor and the other via a costimulatory receptor. As both inflammatory and homeostatic cytokines can become available during inflammatory conditions (in response to infections or sterile inflammation), we started investigating the physiological significance and pathological consequences of such antigen- and co-stimulation- independent activation of naïve T cells. Over the past decade, we have shown that (i) the cytokine-stimulated T cells acquire increased sensitivity to antigens as they respond to limiting amounts of antigens and weakly agonistic antigenic peptides, (ii) such antigen non-specific stimulation can activate autoreactive T cells in vivo, and (iii) this process is regulated by SOCS1. We have also found that the `cytokine-primed' T cells display increased metabolic fitness and marked changes in their plasma membrane that could impact T cell antigen receptor (TCR) signaling. In the proposed research, we aim to understand the mechanistic and molecular basis of the increased antigen responsiveness of cytokine-primed T cells. As our candidate approaches have shown very limited scope, we propose to use unbiased genomic (ATACseq, RNAseq) and proteomic (iTRAQ differential proteomics) approaches to gain a comprehensive view of the molecular changes that occur during cytokine priming. The selected candidate genes/proteins/pathways will be tested for their contribution to cytokine priming using in vitro assays and in vivo models. The proposed research program will put emphasis on training students in cutting-edge technologies of genomics and proteomics, and bioinformatics analyses. In addition they will be trained in several immunology techniques related to animal handling, T cell biology, flow cytometry, confocal microscopy, molecular biology techniques and bioinformatics analyses. The trainees will gain knowledge and skill set suitable for both academic career and industry jobs. The outcome of this research will impact on how cytokines could be exploited for boosting immune responses, and how their signaling pathways could be targeted to control aberrant immune responses.
这项研究的总体目标是了解先天免疫反应中产生的炎性细胞因子如何影响细胞毒性T淋巴细胞的适应性免疫反应。细胞因子反应受细胞因子信号转导抑制因子家族蛋白的调节。在研究缺乏SOCS1的小鼠T细胞室的失控稳态时,我们偶然观察到:SOCS1缺陷的CD8T细胞在调节T细胞稳态的细胞因子的反应下旺盛增殖,这一点被炎性细胞因子放大;虽然这并不出人意料,但对照组小鼠的CD8T细胞也在炎性细胞因子和稳态细胞因子的协同刺激下增殖。后者是意想不到的,因为正常的T细胞需要两个信号-一个通过抗原受体,另一个通过共刺激受体。由于炎症条件下(对感染或无菌炎症的反应)可以获得炎性和稳态细胞因子,我们开始研究这种抗原和共刺激无关的幼稚T细胞激活的生理意义和病理后果。在过去的十年里,我们已经证明:(I)细胞因子刺激的T细胞对有限数量的抗原和弱激动型抗原肽的反应增加了对抗原的敏感性,(Ii)这种抗原的非特异性刺激可以激活体内的自身反应性T细胞,(Iii)这一过程受SOCS1的调控。我们还发现,“细胞因子启动”的T细胞表现出更强的代谢适应性和显著的质膜变化,这可能会影响T细胞抗原受体(TCR)信号转导。在这项拟议的研究中,我们的目标是了解细胞因子诱导的T细胞抗原反应性增强的机制和分子基础。由于我们的候选方法的范围非常有限,我们建议使用无偏基因组学(ATACseq,RNAseq)和蛋白质组学(iTRAQ差异蛋白质组学)方法来全面了解细胞因子启动过程中发生的分子变化。选定的候选基因/蛋白质/途径将使用体外分析和体内模型来测试它们对细胞因子启动的贡献。拟议的研究计划将侧重于培训学生在基因组学和蛋白质组学以及生物信息学分析方面的尖端技术。此外,他们还将接受与动物处理、T细胞生物学、流式细胞术、共聚焦显微镜、分子生物学技术和生物信息学分析有关的几项免疫学技术方面的培训。学员将获得适合学术和行业工作的知识和技能。这项研究的结果将影响如何利用细胞因子来增强免疫反应,以及如何针对它们的信号通路来控制异常免疫反应。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ilangumaran, Subburaj其他文献
Increased antigen responsiveness of naive CD8 T cells exposed to IL-7 and IL-21 is associated with decreased CD5 expression
- DOI:
10.1038/icb.2009.109 - 发表时间:
2010-05-01 - 期刊:
- 影响因子:4
- 作者:
Gagnon, Julien;Chen, Xi L.;Ilangumaran, Subburaj - 通讯作者:
Ilangumaran, Subburaj
The hepatocyte growth factor (HGF)-MET receptor tyrosine kinase signaling pathway: Diverse roles in modulating immune cell functions
- DOI:
10.1016/j.cyto.2015.12.013 - 发表时间:
2016-06-01 - 期刊:
- 影响因子:3.8
- 作者:
Ilangumaran, Subburaj;Villalobos-Hernandez, Alberto;Ramanathan, Sheela - 通讯作者:
Ramanathan, Sheela
IL-6, in synergy with IL-7 or IL-15, stimulates TCR-independent proliferation and functional differentiation of CD8+ T lymphocytes
- DOI:
10.4049/jimmunol.180.12.7958 - 发表时间:
2008-06-15 - 期刊:
- 影响因子:4.4
- 作者:
Gagnon, Julien;Ramanathan, Sheela;Ilangumaran, Subburaj - 通讯作者:
Ilangumaran, Subburaj
SOCS1 controls liver regeneration by regulating HGF signaling in hepatocytes
- DOI:
10.1016/j.jhep.2011.03.027 - 发表时间:
2011-12-01 - 期刊:
- 影响因子:25.7
- 作者:
Gui, Yirui;Yeganeh, Mehdi;Ilangumaran, Subburaj - 通讯作者:
Ilangumaran, Subburaj
Regulation of MET Receptor Signaling by SOCS1 and its Implications for Hepatocellular Carcinoma
- DOI:
10.2174/13816128113199990597 - 发表时间:
2014-05-01 - 期刊:
- 影响因子:3.1
- 作者:
Gui, Yirui;Yeganeh, Mehdi;Ilangumaran, Subburaj - 通讯作者:
Ilangumaran, Subburaj
Ilangumaran, Subburaj的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ilangumaran, Subburaj', 18)}}的其他基金
Molecular mechanisms of cytokine-induced modulation of T cell antigen receptor responsiveness
细胞因子诱导的 T 细胞抗原受体反应性调节的分子机制
- 批准号:
RGPIN-2020-04804 - 财政年份:2022
- 资助金额:
$ 2.33万 - 项目类别:
Discovery Grants Program - Individual
Molecular mechanisms of cytokine-induced modulation of T cell antigen receptor responsiveness
细胞因子诱导的 T 细胞抗原受体反应性调节的分子机制
- 批准号:
RGPIN-2020-04804 - 财政年份:2020
- 资助金额:
$ 2.33万 - 项目类别:
Discovery Grants Program - Individual
Cytokine-induced modulation of T lymphocyte responses to antigens
细胞因子诱导的 T 淋巴细胞对抗原反应的调节
- 批准号:
RGPIN-2014-04692 - 财政年份:2018
- 资助金额:
$ 2.33万 - 项目类别:
Discovery Grants Program - Individual
Cytokine-induced modulation of T lymphocyte responses to antigens
细胞因子诱导的 T 淋巴细胞对抗原反应的调节
- 批准号:
RGPIN-2014-04692 - 财政年份:2017
- 资助金额:
$ 2.33万 - 项目类别:
Discovery Grants Program - Individual
Cytokine-induced modulation of T lymphocyte responses to antigens
细胞因子诱导的 T 淋巴细胞对抗原反应的调节
- 批准号:
RGPIN-2014-04692 - 财政年份:2016
- 资助金额:
$ 2.33万 - 项目类别:
Discovery Grants Program - Individual
Cytokine-induced modulation of T lymphocyte responses to antigens
细胞因子诱导的 T 淋巴细胞对抗原反应的调节
- 批准号:
RGPIN-2014-04692 - 财政年份:2015
- 资助金额:
$ 2.33万 - 项目类别:
Discovery Grants Program - Individual
Cytokine-induced modulation of T lymphocyte responses to antigens
细胞因子诱导的 T 淋巴细胞对抗原反应的调节
- 批准号:
RGPIN-2014-04692 - 财政年份:2014
- 资助金额:
$ 2.33万 - 项目类别:
Discovery Grants Program - Individual
Cytokine-induced modulation of T cell antigen receptor signaling
细胞因子诱导的 T 细胞抗原受体信号传导调节
- 批准号:
342179-2009 - 财政年份:2013
- 资助金额:
$ 2.33万 - 项目类别:
Discovery Grants Program - Individual
Cytokine-induced modulation of T cell antigen receptor signaling
细胞因子诱导的 T 细胞抗原受体信号传导调节
- 批准号:
342179-2009 - 财政年份:2012
- 资助金额:
$ 2.33万 - 项目类别:
Discovery Grants Program - Individual
Cytokine-induced modulation of T cell antigen receptor signaling
细胞因子诱导的 T 细胞抗原受体信号传导调节
- 批准号:
342179-2009 - 财政年份:2011
- 资助金额:
$ 2.33万 - 项目类别:
Discovery Grants Program - Individual
相似国自然基金
Exploring the Intrinsic Mechanisms of CEO Turnover and Market
- 批准号:
- 批准年份:2024
- 资助金额:万元
- 项目类别:外国学者研究基金
Exploring the Intrinsic Mechanisms of CEO Turnover and Market Reaction: An Explanation Based on Information Asymmetry
- 批准号:W2433169
- 批准年份:2024
- 资助金额:万元
- 项目类别:外国学者研究基金项目
Erk1/2/CREB/BDNF通路在CSF1R相关性白质脑病致病机制中的作用研究
- 批准号:82371255
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
Foxc2介导Syap1/Akt信号通路调控破骨/成骨细胞分化促进颞下颌关节骨关节炎的机制研究
- 批准号:82370979
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
MYRF/SLC7A11调控施万细胞铁死亡在三叉神经痛脱髓鞘病变中的作用和分子机制研究
- 批准号:82370981
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
Idh3a作为线粒体代谢—表观遗传检查点调控产热脂肪功能的机制研究
- 批准号:82370851
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
小脑浦肯野细胞突触异常在特发性震颤中的作用机制及靶向干预研究
- 批准号:82371248
- 批准年份:2023
- 资助金额:47.00 万元
- 项目类别:面上项目
声致离子电流促进小胶质细胞M2极化阻断再生神经瘢痕退变免疫机制
- 批准号:82371973
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
GREB1突变介导雌激素受体信号通路导致深部浸润型子宫内膜异位症的分子遗传机制研究
- 批准号:82371652
- 批准年份:2023
- 资助金额:45.00 万元
- 项目类别:面上项目
用于小尺寸管道高分辨成像荧光聚合物点的构建、成像机制及应用研究
- 批准号:82372015
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
相似海外基金
Molecular mechanisms regulating LMO2+ metastasis initiating cells
调节LMO2转移起始细胞的分子机制
- 批准号:
10659840 - 财政年份:2023
- 资助金额:
$ 2.33万 - 项目类别:
Elucidating and bypassing molecular mechanisms that suppress Muller glia-dependent regeneration of cones in two zebrafish models of chronic retinal damage
阐明和绕过抑制两种慢性视网膜损伤斑马鱼模型中穆勒胶质细胞依赖性视锥细胞再生的分子机制
- 批准号:
10567836 - 财政年份:2023
- 资助金额:
$ 2.33万 - 项目类别:
A novel genetic mutation reveals the molecular and cellular mechanisms of severe recurrent skin inflammation
一种新的基因突变揭示了严重复发性皮肤炎症的分子和细胞机制
- 批准号:
10679177 - 财政年份:2023
- 资助金额:
$ 2.33万 - 项目类别:
Revealing mechanisms of specificity and adaptability in molecular information processing through data-driven models
通过数据驱动模型揭示分子信息处理的特异性和适应性机制
- 批准号:
10715575 - 财政年份:2023
- 资助金额:
$ 2.33万 - 项目类别:
Defining molecular mechanisms by which stimulant evoked dopamine drives inflammation and neuronal dysfunction in neuroHIV
定义兴奋剂诱发多巴胺驱动神经艾滋病毒炎症和神经元功能障碍的分子机制
- 批准号:
10685160 - 财政年份:2023
- 资助金额:
$ 2.33万 - 项目类别:
Molecular mechanisms of posttranscriptional gene regulation in asthmatic airway inflammation
哮喘气道炎症转录后基因调控的分子机制
- 批准号:
10698606 - 财政年份:2023
- 资助金额:
$ 2.33万 - 项目类别:
Molecular Mechanisms by which Statins Prevent and Reverse Hepatocellular Carcinoma
他汀类药物预防和逆转肝细胞癌的分子机制
- 批准号:
10856787 - 财政年份:2023
- 资助金额:
$ 2.33万 - 项目类别:
Molecular Mechanisms Associated with Insomnia and Response to Cognitive Behavioral Therapy for Insomnia
与失眠相关的分子机制以及对失眠认知行为疗法的反应
- 批准号:
10590036 - 财政年份:2023
- 资助金额:
$ 2.33万 - 项目类别:
Analyzing genetic and environmental molecular mechanisms causing autoimmune thyroid diseases
分析导致自身免疫性甲状腺疾病的遗传和环境分子机制
- 批准号:
10693959 - 财政年份:2022
- 资助金额:
$ 2.33万 - 项目类别:
Analyzing genetic and environmental molecular mechanisms causing autoimmune thyroid diseases
分析导致自身免疫性甲状腺疾病的遗传和环境分子机制
- 批准号:
10517531 - 财政年份:2022
- 资助金额:
$ 2.33万 - 项目类别: